Latamoxef-induced severe thrombocytopenia during the treatment of pulmonary infection: A case report

Figure 1 Changes of white blood cell, hemoglobin, platelet count, and medication during hospitalization. A: White blood cell count during hospitalization. B: Hemoglobin count during hospitalization; and C: Platelet count and timing of medications during hospitalization. LMOX: Latamoxef; RD: Rifampicin; INH: Isoniazid; EB: Ethambutol; PZA: Pyrazinamide; LEV: Levofloxacin; rhTPO: Recombinant human thrombopoietin; IVIG: Intravenous immunoglobulin, DXM: Dexamethasone, VK1: Vitamin K1.

Figure 2 The occurrence of skin ecchymosis during hospitalization and before discharge. A: Skin ecchymosis during latamoxef treatment; B: Skin ecchymosis after withdrawal of latamoxef (before discharge).